Along with the Breslow thickness, the Melanoma CDSS includes features such as the relative number of tumors infiltrating L-BCL2+ and serum levels of IL-4 or IL-6, all of which have been reported to be important risk factors for melanoma progression [9]. Here, BCL2 is linked to melanoma.